December, 2023
December 2023
OncoDaily Dialogues #1 – Harout Semerjian / Hosted by Roupen Odabashian
28/09/2023 15:04

OncoDaily Dialogues #1 – Harout Semerjian / Hosted by Roupen Odabashian

We’re thrilled to launch our new series, “OncoDaily Dialogues”. This initiative by OncoDaily is designed to spotlight leaders in the field of oncology, sharing their stories of success, challenges, and life lessons.

For our inaugural dialogue, we’re honored to welcome Harout Semerjian, the President and CEO of GlycoMimetics, as our guest. Mr. Semerjian possesses extensive experience in both biotech and big pharma. He began his career as a pharma representative in Lebanon before ascending to a leadership role at the multinational giant, Novartis. When he departed the company, he held the position of Senior Vice President and Global Launch Lead for Ribociclib. Subsequently, before joining GlycoMimetics, he served as the President and Chief Executive Officer of Immunomedics and as EVP and Chief Commercial Officer of Ipsen. Harout earned his MBAs from Cornell Johnson Graduate School of Management and Queen’s University, and he holds a Bachelor’s degree in Biology from the Lebanese American University.

Our host is Dr. Roupen Odabashian, hematology/oncology fellow at Karmanos Cancer Institute in Detroit, USA. Beyond his clinical practice, Dr. Odabashian possesses an unwavering passion for delving into the intricacies of healthcare policy, regulations and Oncology. He understands the multifaceted nature of cancer as a medical condition and acknowledges the various stakeholders and regulatory bodies that influence the delivery and administration of Cancer treatments. In alignment with this commitment, he has joined OncoDaily, where he plays a pivotal role in conducting interviews with Leaders of the Cancer world.